Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Revenue

In the year 2025, Oryzon Genomics had annual revenue of $13.70M USD with 73.83% growth.

• Revenue: $13.70M
• Revenue Growth: +73.83%
• P/S Ratio: 21.75
• Revenue / Employee: $297.75K
• Employees: 46
• Market Cap: 237.84M EUR

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.70M	5.82M	73.83%
Dec 31, 2024	7.88M	-7.98M	-50.31%
Dec 31, 2023	15.86M	-1.26M	-7.34%
Dec 31, 2022	17.11M	4.85M	39.56%
Dec 31, 2021	12.26M	545.30K	4.65%
Dec 31, 2020	11.72M	146.90K	1.27%
Dec 31, 2019	11.57M	3.36M	40.98%
Dec 31, 2018	8.21M	2.52M	44.42%
Dec 31, 2017	5.68M	14.63K	0.26%
Dec 31, 2016	5.67M	1.02M	21.97%
Dec 31, 2015	4.65M	-15.21M	-76.60%
Dec 31, 2014	19.86M	15.61M	367.13%
Dec 31, 2013	4.25M	-2.47M	-36.78%
Dec 31, 2012	6.72M	-1.01M	-13.07%
Dec 31, 2011	7.73M	-	-

Data Source: Fiscal.ai Last updated: May 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 17, 2026

Data Sources Report a data error